Review

cd40l blocking agent (Bio X Cell)

Bio X Cell is a verified supplier

Bio X Cell manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Bio X Cell cd40l blocking agent
Cd40l Blocking Agent, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd40l+blocking+antibody/InVivoMAb+anti-mouse+CD40L/pm41785084-801-22-25
Average 95 stars, based on 176 article reviews

cd40l blocking agent - by Bioz Stars, 2026-09

95/100 stars

Images

Blocking Assay:

Article Title: Transient silencing of hypermutation preserves B cell affinity during clonal bursting.
Article Snippet: The following day, 2,000 DHB–tdTomato- and H2B–GFP-expressing GC B cells were sorted into each well and supplemented with 150 μl of OptiMEM along with 30 μg ml−1 LPS (Sigma-Aldrich) and 4 ng ml−1 IL-4 (Thermo Fisher Scientific). .. Anti-CD40L blocking antibody (25 μg ml−1, Bio X Cell) was added as indicated. .. Time-lapse imaging was performed on CellDiscoverer7 (Zeiss) with a 20× objective.

Article Title: Transient silencing of hypermutation preserves B cell affinity during clonal bursting
Article Snippet: The following day, 2,000 DHB–tdTomato- and H2B–GFP-expressing GC B cells were sorted into each well and supplemented with 150 μl of OptiMEM along with 30 μg ml −1 LPS (Sigma-Aldrich) and 4 ng ml −1 IL-4 (Thermo Fisher Scientific). .. Anti-CD40L blocking antibody (25 μg ml −1 , Bio X Cell) was added as indicated. .. Time-lapse imaging was performed on CellDiscoverer7 (Zeiss) with a 20× objective.

Article Title: Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Article Snippet: After surface marker staining, splenocytes were subjected to fixation, permeabilization, and click reaction to fluorescently label incorporated EdU with AF488 following the instruction from the Click-iT Plus EdU Flow Cytometry Assay Kit (ThermoFisher; C10632). .. For CD40L blocking assay, SRBC-immunized BM chimeric mice were administered with either anti-CD40L blocking antibody (Bio X Cell BE0017-1, 100 ug/mouse via IV) or IgG control antibody (Bio X Cell BE0091, 100 ug/mouse via IV) at day 4 and 6 post SRBC, followed by splenic GC analysis at day 8 post SRBC. ..

Article Title: Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.
Article Snippet: For CD40L blocking assay, SRBC-immunized BM chimeric mice were administered with either anti-CD40L blocking antibody (Bio X Cell BE0017-1, 100 ug/mouse via IV) or IgG control antibody (Bio XCell BE0091, 100 ug/mouse via IV) at day 4 and 6 post SRBC, followed by splenic GC analysis at day 8 post SRBC. .. For CD40L blocking assay, SRBC-immunized BM chimeric mice were administered with either anti-CD40L blocking antibody (Bio X Cell BE0017-1, 100 ug/mouse via IV) or IgG control antibody (Bio XCell BE0091, 100 ug/mouse via IV) at day 4 and 6 post SRBC, followed by splenic GC analysis at day 8 post SRBC. .. After red blood cell lysis using the ACK lysing buffer (Lonza; BP10-548E), 1 × 106 cells were injected into the retro-orbital sinus of lethally irradiated C57BL/6J recipient mice (2 doses of 450 rad, 12 h apart, on a Rad Source Technologies RS 2000 X-ray Irradiator).

Control:

Image Search Results

a , Proposed model for AID and/or SHM activity. b , Detecting CDK2 activity through subcellular translocation of a DHB reporter. c , Rosa26 DHB-tdTomato knock-in (KI) allele design. Asterisk denotes a silent mutation introduced to prevent sgRNA binding in the KI template. d , DHB–tdTomato (red) and H2B–GFP (green) in cultured GC B cells, with corresponding C/N ratios. Scale bars, 5 μm. e , Snapshots from time-lapse imaging of GC B cells in Nojima cultures expressing H2B–GFP (green) and DHB–tdTomato (red at the top, greyscale at the bottom; Supplementary Video ). Scale bar, 10 µm. f , CDK2 activity traces (grey) with mean ± s.d. (red). Cells treated with anti-CD40L blocking antibody (blue) provide a CDK2 low reference. g , Duration of the C/N ratio below 1.0 (S-phase entry) after anaphase. Each symbol represents one daughter cell. h , DHB–tdTomato (red) and H2B–GFP (green) in GC B cells. CD35 expression (yellow dotted line) delineates the LZ (Supplementary Video ). Arrowheads in insets highlight nuclear DHB–tdTomato in LZ cells and cytoplasmic expression in DZ cells. Scale bars, 50 µm (top); 20 µm (bottom). i , DHB–tdTomato (grey) after treatment with anti-DEC-OVA. Arrowheads highlight nuclear DHB–tdTomato at 72 h. Scale bars, 20 µm. j , Violin plot of CDK2 activity with box plot overlay (median, interquartile range, range). The grey box indicates the CDK2 low state (median of untreated LZ cells). Individual GC data are in Extended Data Fig. . k , Fraction of CDK2 low cells in paired LZ and DZ cells in untreated GCs and DZ B cells after treatment with anti-DEC-OVA. P values by Student’s t -test. l , Snapshots of DHB–tdTomato (red) and H2B–GFP (green) from intravital time-lapse imaging at 0 h or 36 h after treatment with anti-DEC-OVA (Supplementary Videos and ). Images are aligned to the time of anaphase, determined by sister chromatid separation (arrowheads). CDK2 activity is indicated for each daughter cell. Scale bars, 10 µm. m , In vivo CDK2 activity traces in DZ cells with or without treatment with anti-DEC-OVA, summarized with mean and s.d. Non-dividing LZ cells (blue) serve as a CDK2 low reference. P value by Student’s t-test.

Journal: Nature

Article Title: Transient silencing of hypermutation preserves B cell affinity during clonal bursting

doi: 10.1038/s41586-025-08687-8

Figure Lengend Snippet: a , Proposed model for AID and/or SHM activity. b , Detecting CDK2 activity through subcellular translocation of a DHB reporter. c , Rosa26 DHB-tdTomato knock-in (KI) allele design. Asterisk denotes a silent mutation introduced to prevent sgRNA binding in the KI template. d , DHB–tdTomato (red) and H2B–GFP (green) in cultured GC B cells, with corresponding C/N ratios. Scale bars, 5 μm. e , Snapshots from time-lapse imaging of GC B cells in Nojima cultures expressing H2B–GFP (green) and DHB–tdTomato (red at the top, greyscale at the bottom; Supplementary Video ). Scale bar, 10 µm. f , CDK2 activity traces (grey) with mean ± s.d. (red). Cells treated with anti-CD40L blocking antibody (blue) provide a CDK2 low reference. g , Duration of the C/N ratio below 1.0 (S-phase entry) after anaphase. Each symbol represents one daughter cell. h , DHB–tdTomato (red) and H2B–GFP (green) in GC B cells. CD35 expression (yellow dotted line) delineates the LZ (Supplementary Video ). Arrowheads in insets highlight nuclear DHB–tdTomato in LZ cells and cytoplasmic expression in DZ cells. Scale bars, 50 µm (top); 20 µm (bottom). i , DHB–tdTomato (grey) after treatment with anti-DEC-OVA. Arrowheads highlight nuclear DHB–tdTomato at 72 h. Scale bars, 20 µm. j , Violin plot of CDK2 activity with box plot overlay (median, interquartile range, range). The grey box indicates the CDK2 low state (median of untreated LZ cells). Individual GC data are in Extended Data Fig. . k , Fraction of CDK2 low cells in paired LZ and DZ cells in untreated GCs and DZ B cells after treatment with anti-DEC-OVA. P values by Student’s t -test. l , Snapshots of DHB–tdTomato (red) and H2B–GFP (green) from intravital time-lapse imaging at 0 h or 36 h after treatment with anti-DEC-OVA (Supplementary Videos and ). Images are aligned to the time of anaphase, determined by sister chromatid separation (arrowheads). CDK2 activity is indicated for each daughter cell. Scale bars, 10 µm. m , In vivo CDK2 activity traces in DZ cells with or without treatment with anti-DEC-OVA, summarized with mean and s.d. Non-dividing LZ cells (blue) serve as a CDK2 low reference. P value by Student’s t-test.

Article Snippet: Anti-CD40L blocking antibody (25 μg ml −1 , Bio X Cell) was added as indicated.

Techniques: Activity Assay, Translocation Assay, Knock-In, Mutagenesis, Binding Assay, Cell Culture, Imaging, Expressing, Blocking Assay, In Vivo

(A) Experimental approach for CD40L blocking experiments. WT mice were either transfused with HOD RBCs or vaccinated with HEL-OVA/Alum. They received CD40L blocking antibody 4 days after immunization and subsequently on days 7 and 10 pi. Sera were collected 2 weeks after immunization for assessment of IgG levels by limiting dilution ELISA. (B) IgG titers of transfused mice. (C) IgG titers of vaccinated mice. (D) Experimental approach for experiments that utilized BCL6-BKO mice. WT or BCL6-BKO mice were either transfused with HOD RBCs or vaccinated with HEL-OVA/Alum. Sera were collected 2 weeks after immunization for assessment of IgG levels by limiting dilution ELISA. (E) IgG titers of transfused mice. (F) IgG titers of vaccinated mice. Each data point represents on mouse. Bars on scatter plots are median values. Figure shows a representative experiment out of 3. Groups of interest were compared using Mann-Whitney U tests preceded by Kruskal-Wallis tests. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns P>0.5.

Journal: bioRxiv

Article Title: Transfusion of allogenic murine HOD red blood cells preferentially induces low-affinity, short-lived IgG antibodies that are germinal center independent

doi: 10.1101/2025.01.16.633377

Figure Lengend Snippet: (A) Experimental approach for CD40L blocking experiments. WT mice were either transfused with HOD RBCs or vaccinated with HEL-OVA/Alum. They received CD40L blocking antibody 4 days after immunization and subsequently on days 7 and 10 pi. Sera were collected 2 weeks after immunization for assessment of IgG levels by limiting dilution ELISA. (B) IgG titers of transfused mice. (C) IgG titers of vaccinated mice. (D) Experimental approach for experiments that utilized BCL6-BKO mice. WT or BCL6-BKO mice were either transfused with HOD RBCs or vaccinated with HEL-OVA/Alum. Sera were collected 2 weeks after immunization for assessment of IgG levels by limiting dilution ELISA. (E) IgG titers of transfused mice. (F) IgG titers of vaccinated mice. Each data point represents on mouse. Bars on scatter plots are median values. Figure shows a representative experiment out of 3. Groups of interest were compared using Mann-Whitney U tests preceded by Kruskal-Wallis tests. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns P>0.5.

Article Snippet: For CD40L blocking experiments, mice were given 250 μg of the anti-mouse CD40L blocking antibody or isotype control via IP injection (BioXCell, BE0017-1 or BE0091) on days 4, 7, 10, and 14 post-immunization.

Techniques: Blocking Assay, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY

a Comparison of the total number of intrahepatic effector gBT-1 T cells at 14 days post-rAAV treatment in recipient mice treated with anti-CD4 depleting, anti-CD40L blocking Ab, or isotype control Ab. b Comparison of the total number of intrahepatic effector gBT-1 T cells at 15 days post-rAAV treatment of recipient mice treated with isotype control, or CD40L blocking Abs beginning day 0 or day 9 post-rAAV. c Comparison of the total number of intrahepatic effector gBT-1 T cells at 15 days post-rAAV treatment of CD4-depleted recipient mice administered agonist anti-CD40 mAb or isotype control 9-days post-rAAV. d Representative IF image of a portal tract cluster containing transferred gBT-1 and P25 T cells interacting with MHCII high cells in the liver 12-days post-rAAV treatment of recipient mice. Data are representative of two independent experiments. n = 4 ( a ) or n = 5 ( b ), n = 4 or 5 ( c ), n = 3 mice per group. Error bars indicate ± SEM. Analysed with one-way ANOVA with Tukey’s multiple comparisons test ( a , b ), or a two-tailed Student’s t test (c). Scale bars, 40 μm/20 μm ( d ). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs

doi: 10.1038/s41467-024-45612-5

Figure Lengend Snippet: a Comparison of the total number of intrahepatic effector gBT-1 T cells at 14 days post-rAAV treatment in recipient mice treated with anti-CD4 depleting, anti-CD40L blocking Ab, or isotype control Ab. b Comparison of the total number of intrahepatic effector gBT-1 T cells at 15 days post-rAAV treatment of recipient mice treated with isotype control, or CD40L blocking Abs beginning day 0 or day 9 post-rAAV. c Comparison of the total number of intrahepatic effector gBT-1 T cells at 15 days post-rAAV treatment of CD4-depleted recipient mice administered agonist anti-CD40 mAb or isotype control 9-days post-rAAV. d Representative IF image of a portal tract cluster containing transferred gBT-1 and P25 T cells interacting with MHCII high cells in the liver 12-days post-rAAV treatment of recipient mice. Data are representative of two independent experiments. n = 4 ( a ) or n = 5 ( b ), n = 4 or 5 ( c ), n = 3 mice per group. Error bars indicate ± SEM. Analysed with one-way ANOVA with Tukey’s multiple comparisons test ( a , b ), or a two-tailed Student’s t test (c). Scale bars, 40 μm/20 μm ( d ). Source data are provided as a Source Data file.

Article Snippet: To block CD40L in vivo, mice were injected i.v. with 500 μg MR1 anti-mouse CD40L blocking mAb (BioXcell, West Lebanon, USA) or polyclonal Armenian hamster IgG isotype control (BioXcell, West Lebanon, USA) in PBS at the indicated time points.

Techniques: Comparison, Blocking Assay, Control, Two Tailed Test

a – c Representative confocal IF images of the liver of XCR1 Venus/+ rAAV-treated recipient mice at 12-days post rAAV, showing large clusters of XCR1 + cDC1s, gBT-1 and P25 T cells in PT regions Scale bars 50 μm ( a ), 30 μm ( b ), 4 μm/2 μm ( c ). d , e Quantification of the average distance (μm) separating XCR1 + cells with gBT-1 T cells and ( d ), or with P25 T cells ( e ) in portal tracts (PT), peri-central vein (PCV) and sinusoidal (S) liver regions. Data points represent a single region of interest from n = 7 mice from 2 independent experiments. f , g Hepatic XCR1 + cDC1 isolated from recipient mice treated, 12-days prior, with rAAV gB-Ag85b or PBS, were assessed for their ability to activate and induce proliferation (assessed by CD44 upregulation and CTV dilution), of naive gBT-1 ( f ) or P25 ( g ) T cells co-cultured for 72 h. h , i Same as ( f , g ) but recipient mice were also treated with isotype control (black) or anti-CD40L blocking mAb (red) to assess the role of CD40/CD40L interactions. Representative flow plots ( h ), and proportion of proliferating CD44 high CTV low gBT-1 T cells ( i ). j Co-stimulatory molecule expression levels in hepatic cDC1s isolated from rAAV gB-Ag85b –treated mice that also received isotype control (black) or anti-CD4 depleting mAb (red) at 12-days post rAAV. k , l Quantification of Ki67 + gB T-1 T cell numbers forming clusters in PT ( k ) and PCV regions ( l ) at 12-days post-rAAV treatment in XCR1 +/+ (black) and XCR1 DTR/+ (red) recipient mice treated with DTx, 9-days prior. m , n Quantification of total numbers of intrahepatic ( m ) and splenic ( n ) effector gBT-1 cell in recipient mice treated with rAAV, 15-days prior. Comparison between diphtheria toxin treated XCR1 +/+ (black) and XCR1 DTR/+ (red) recipient mice at 9-days post-rAAV.Data representative of two independent experiments. n = 5 ( a – c ), n = 7 ( d , e ), n = 3 or 4 ( f , g ), n = 7 ( i ), n = 4 ( j ) n = 5 ( k , l ) and n = 6 ( m , n ) mice per group. Error bars indicate ± SEM. Analysed with a Kruskal-Wallis test with multiple comparisons ( d , e ), a two-tailed unpaired Student’s t test ( i , j ) or a two tailed unpaired Mann–Whitney U test ( k – n ); ns not statistically significant. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs

doi: 10.1038/s41467-024-45612-5

Figure Lengend Snippet: a – c Representative confocal IF images of the liver of XCR1 Venus/+ rAAV-treated recipient mice at 12-days post rAAV, showing large clusters of XCR1 + cDC1s, gBT-1 and P25 T cells in PT regions Scale bars 50 μm ( a ), 30 μm ( b ), 4 μm/2 μm ( c ). d , e Quantification of the average distance (μm) separating XCR1 + cells with gBT-1 T cells and ( d ), or with P25 T cells ( e ) in portal tracts (PT), peri-central vein (PCV) and sinusoidal (S) liver regions. Data points represent a single region of interest from n = 7 mice from 2 independent experiments. f , g Hepatic XCR1 + cDC1 isolated from recipient mice treated, 12-days prior, with rAAV gB-Ag85b or PBS, were assessed for their ability to activate and induce proliferation (assessed by CD44 upregulation and CTV dilution), of naive gBT-1 ( f ) or P25 ( g ) T cells co-cultured for 72 h. h , i Same as ( f , g ) but recipient mice were also treated with isotype control (black) or anti-CD40L blocking mAb (red) to assess the role of CD40/CD40L interactions. Representative flow plots ( h ), and proportion of proliferating CD44 high CTV low gBT-1 T cells ( i ). j Co-stimulatory molecule expression levels in hepatic cDC1s isolated from rAAV gB-Ag85b –treated mice that also received isotype control (black) or anti-CD4 depleting mAb (red) at 12-days post rAAV. k , l Quantification of Ki67 + gB T-1 T cell numbers forming clusters in PT ( k ) and PCV regions ( l ) at 12-days post-rAAV treatment in XCR1 +/+ (black) and XCR1 DTR/+ (red) recipient mice treated with DTx, 9-days prior. m , n Quantification of total numbers of intrahepatic ( m ) and splenic ( n ) effector gBT-1 cell in recipient mice treated with rAAV, 15-days prior. Comparison between diphtheria toxin treated XCR1 +/+ (black) and XCR1 DTR/+ (red) recipient mice at 9-days post-rAAV.Data representative of two independent experiments. n = 5 ( a – c ), n = 7 ( d , e ), n = 3 or 4 ( f , g ), n = 7 ( i ), n = 4 ( j ) n = 5 ( k , l ) and n = 6 ( m , n ) mice per group. Error bars indicate ± SEM. Analysed with a Kruskal-Wallis test with multiple comparisons ( d , e ), a two-tailed unpaired Student’s t test ( i , j ) or a two tailed unpaired Mann–Whitney U test ( k – n ); ns not statistically significant. Source data are provided as a Source Data file.

Techniques: Isolation, Cell Culture, Control, Blocking Assay, Expressing, Comparison, Two Tailed Test, MANN-WHITNEY

IL-21 regulates light zone GC B cell selection. (A) Wild-type (WT) mice were immunized with SRBC and either treated with blocking anti-CD40L antibody (MR1; 200 μg/i.p. injection on days 5 and 6 after immunization) or received no further treatment (Control). Collated data (left) and representative flow cytometry plots (right) for c-Myc+BATF+IRF4+ splenic light zone (LZ; CXCR4 low CD86 high ) GC B cell (CD19+BCL6+) frequencies 7 d after immunization; color scales define IRF4 expression levels in each cell. (B) WT mice were immunized with SRBC and either treated with agonistic CD40 antibody (FGK4.5; 50 μg i.p on day 5 after immunization) or received no further treatment (Control). Collated data (left) and representative flow cytometry plots (right) for c-Myc+BATF+IRF4+ splenic light zone GC B cell frequencies 6 d after immunization; color scales define IRF4 expression levels in each cell. (C) p-S6 expression was analyzed in splenic GC from SRBC-immunized WT mice 6 d after immunization. Representative histograms showing p-S6 expression mean fluorescence intensity (MFI) in c-Myc+BATF+IRF4+ and c-Myc−BATF−IRF4− light zone GC B cells compared to follicular B cells (CD19+IgD+BCL6−; left). Collated data for p-S6 expression in c-Myc+BATF+IRF4+ and c-Myc−BATF−IRF4− light zone and all dark zone (DZ; CXCR4 high CD86 low ) GC B cells (right). Data are collated from two to four independent experiments; n = 4–14; Mann–Whitney U test or Kruskal–Wallis test. (D) CD19+ cells were isolated from spleens of 10-wk-old WT BALB/c mice using MACS positive selection. Cells were stimulated using 0–60 ng/ml of IL-21 and 20 μg/ml of anti-CD40 mAb for 24 h. Collated data and representative histograms for p-S6 median fluorescence intensity. One-way ANOVA; n = 4. (E) Representative t-SNE plots showing expression of c-Myc, BATF, and IRF4 in concatenated CTLA-4−/− and IL-21R−/−CTLA-4−/− light zone GC B cells; color scales define protein expression levels in each cell. (F) Collated data for c-Myc+BATF+IRF4+ splenic light zone GC B cell frequencies in 17–21-d-old CTLA-4−/− and IL-21R−/−CTLA-4−/− mice. Data are collated from five independent experiments; n = 8–9; Mann–Whitney U test. Mean ± SD are shown; ****, P < 0.0001; **, P < 0.01; *, P < 0.05.

Journal: The Journal of Experimental Medicine

Article Title: IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation

doi: 10.1084/jem.20221653

Figure Lengend Snippet: IL-21 regulates light zone GC B cell selection. (A) Wild-type (WT) mice were immunized with SRBC and either treated with blocking anti-CD40L antibody (MR1; 200 μg/i.p. injection on days 5 and 6 after immunization) or received no further treatment (Control). Collated data (left) and representative flow cytometry plots (right) for c-Myc+BATF+IRF4+ splenic light zone (LZ; CXCR4 low CD86 high ) GC B cell (CD19+BCL6+) frequencies 7 d after immunization; color scales define IRF4 expression levels in each cell. (B) WT mice were immunized with SRBC and either treated with agonistic CD40 antibody (FGK4.5; 50 μg i.p on day 5 after immunization) or received no further treatment (Control). Collated data (left) and representative flow cytometry plots (right) for c-Myc+BATF+IRF4+ splenic light zone GC B cell frequencies 6 d after immunization; color scales define IRF4 expression levels in each cell. (C) p-S6 expression was analyzed in splenic GC from SRBC-immunized WT mice 6 d after immunization. Representative histograms showing p-S6 expression mean fluorescence intensity (MFI) in c-Myc+BATF+IRF4+ and c-Myc−BATF−IRF4− light zone GC B cells compared to follicular B cells (CD19+IgD+BCL6−; left). Collated data for p-S6 expression in c-Myc+BATF+IRF4+ and c-Myc−BATF−IRF4− light zone and all dark zone (DZ; CXCR4 high CD86 low ) GC B cells (right). Data are collated from two to four independent experiments; n = 4–14; Mann–Whitney U test or Kruskal–Wallis test. (D) CD19+ cells were isolated from spleens of 10-wk-old WT BALB/c mice using MACS positive selection. Cells were stimulated using 0–60 ng/ml of IL-21 and 20 μg/ml of anti-CD40 mAb for 24 h. Collated data and representative histograms for p-S6 median fluorescence intensity. One-way ANOVA; n = 4. (E) Representative t-SNE plots showing expression of c-Myc, BATF, and IRF4 in concatenated CTLA-4−/− and IL-21R−/−CTLA-4−/− light zone GC B cells; color scales define protein expression levels in each cell. (F) Collated data for c-Myc+BATF+IRF4+ splenic light zone GC B cell frequencies in 17–21-d-old CTLA-4−/− and IL-21R−/−CTLA-4−/− mice. Data are collated from five independent experiments; n = 8–9; Mann–Whitney U test. Mean ± SD are shown; ****, P < 0.0001; **, P < 0.01; *, P < 0.05.

Article Snippet: When indicated, anti-CD40L blocking antibodies (clone MR-1; Bio X Cell) were injected i.p. 5.5 and 6.5 d after SRBC immunization (200 μg per injection), and agonistic anti-CD40 antibodies (clone FGK4.5; Bio X Cell) were injected 5 d after SRBC immunization (50 μg per injection).

Techniques: Selection, Blocking Assay, Injection, Control, Flow Cytometry, Expressing, Fluorescence, MANN-WHITNEY, Isolation